<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>44</volume><submitter>Huang J</submitter><pubmed_abstract>The significance of collagen and vascular in skin augmentation have been recognized in recent years. However, current skin tissue fillers, &lt;i>e.g.&lt;/i> hyaluronic acid (HA) or HA-based hydrogel, fail to meet the perfect augmentation requirements due to their inadequate long-term support effect and the lack of tissue-inducing activity. Herein, an injectable skin filler containing hyaluronic acid (HA) hydrogel and lithium calcium silicate (LCS, Li&lt;sub>2&lt;/sub>Ca&lt;sub>4&lt;/sub>Si&lt;sub>4&lt;/sub>O&lt;sub>13&lt;/sub>) bioceramic microspheres was developed for skin tissue fillers, owing to the excellent biological function of silicate bioceramics. The HA-LCS fillers could be easily injected through a tiny standard medical needle (27 G) with force of less than 36 N, and showed good biocompatibility both &lt;i>in v</pubmed_abstract><journal>Bioactive materials</journal><pagination>256-268</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11539074</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>An injectable hyaluronic acid/lithium calcium silicate soft tissue filler with vascularization and collagen regeneration.</pubmed_title><pmcid>PMC11539074</pmcid><pubmed_authors>Zhai D</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Zhu Y</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Wu C</pubmed_authors><pubmed_authors>Xue J</pubmed_authors><pubmed_authors>Du L</pubmed_authors><pubmed_authors>Huan Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>An injectable hyaluronic acid/lithium calcium silicate soft tissue filler with vascularization and collagen regeneration.</name><description>The significance of collagen and vascular in skin augmentation have been recognized in recent years. However, current skin tissue fillers, &lt;i>e.g.&lt;/i> hyaluronic acid (HA) or HA-based hydrogel, fail to meet the perfect augmentation requirements due to their inadequate long-term support effect and the lack of tissue-inducing activity. Herein, an injectable skin filler containing hyaluronic acid (HA) hydrogel and lithium calcium silicate (LCS, Li&lt;sub>2&lt;/sub>Ca&lt;sub>4&lt;/sub>Si&lt;sub>4&lt;/sub>O&lt;sub>13&lt;/sub>) bioceramic microspheres was developed for skin tissue fillers, owing to the excellent biological function of silicate bioceramics. The HA-LCS fillers could be easily injected through a tiny standard medical needle (27 G) with force of less than 36 N, and showed good biocompatibility both &lt;i>in v</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-04-04T09:36:46.278Z</modification><creation>2025-04-04T09:36:46.278Z</creation></dates><accession>S-EPMC11539074</accession><cross_references><pubmed>39507373</pubmed><doi>10.1016/j.bioactmat.2024.10.014</doi></cross_references></HashMap>